Atıf Formatları
Targeted siRNA lipid nanoparticles for the treatment of KRAS-mutant tumors
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

S. Anthiya Et Al. , "Targeted siRNA lipid nanoparticles for the treatment of KRAS-mutant tumors," Journal of Controlled Release , vol.357, pp.67-83, 2023

Anthiya, S. Et Al. 2023. Targeted siRNA lipid nanoparticles for the treatment of KRAS-mutant tumors. Journal of Controlled Release , vol.357 , 67-83.

Anthiya, S., ÖZTÜRK, S. C., Yanik, H., Tavukcuoglu, E., ŞAHİN, A., Datta, D., ... Charisse, K.(2023). Targeted siRNA lipid nanoparticles for the treatment of KRAS-mutant tumors. Journal of Controlled Release , vol.357, 67-83.

Anthiya, Shubaash Et Al. "Targeted siRNA lipid nanoparticles for the treatment of KRAS-mutant tumors," Journal of Controlled Release , vol.357, 67-83, 2023

Anthiya, Shubaash Et Al. "Targeted siRNA lipid nanoparticles for the treatment of KRAS-mutant tumors." Journal of Controlled Release , vol.357, pp.67-83, 2023

Anthiya, S. Et Al. (2023) . "Targeted siRNA lipid nanoparticles for the treatment of KRAS-mutant tumors." Journal of Controlled Release , vol.357, pp.67-83.

@article{article, author={Shubaash Anthiya Et Al. }, title={Targeted siRNA lipid nanoparticles for the treatment of KRAS-mutant tumors}, journal={Journal of Controlled Release}, year=2023, pages={67-83} }